As a result of Medincell technology, a long-acting injectable formulation of olanzapine may be widely used by patients with schizophrenia.” The pivotal clinical phase 3 trial for the olanzapine ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Richard Malamut, Chief Medical Officer at Medincell comments: "Our partner is advancing the clinical development of the olanzapine LAI with plans for regulatory submission in the US. This structured ...

Implementation of a policy that increased pharmacist surveillance and regulation of the use of intramuscular olanzapine reduced the potential for coadministration of the agent with parenteral ...

They called it the “VIVA ZYPREXA” campaign to off label market Eli Lilly Zyprexa as a fix for unapproved usage. Zyprexa (Olanzapine) is known as an atypical antipsychotic It’s ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Multivariable Poisson regression was used to determine associations between sex ... of those receiving risperidone and 62% (n=7094) of those receiving olanzapine (table 4). More than half of the ...

“It is hard to understand how a price exceeding usual cost-effectiveness thresholds is appropriate for a treatment that could be very widely used,” he continued, “particularly when that ...